联泓新科: 2025年半年度报告摘要

Core Viewpoint - The report highlights a decrease in revenue but an increase in net profit for the first half of 2025, indicating a potential shift in operational efficiency despite lower sales [1]. Financial Performance - Operating revenue for the first half of 2025 was approximately ¥2.91 billion, a decrease of 12.13% compared to ¥3.31 billion in the same period last year [1]. - Net profit attributable to shareholders was approximately ¥160.67 million, an increase of 14.15% from ¥140.76 million in the previous year [1]. - Net profit after deducting non-recurring gains and losses was not specified but is implied to be positive [1]. - Net cash flow from operating activities was approximately ¥259.93 million, up 4.49% from ¥248.76 million [1]. - Basic and diluted earnings per share were both ¥0.12, reflecting a 9.09% increase from ¥0.11 [1]. - The weighted average return on equity was 2.20%, up from 1.97% [1]. Asset and Equity Position - Total assets at the end of the reporting period were approximately ¥22.10 billion, an increase of 13.19% from ¥19.52 billion at the end of the previous year [1]. - Net assets attributable to shareholders were approximately ¥7.31 billion, a slight increase of 0.99% from ¥7.24 billion [1]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 54,222 [3]. - The largest shareholder, 联泓集团有限公司, holds 48.77% of the shares, while 中国科学院控股有限公司 holds 25.27% [3]. - There were no changes in the controlling shareholder or actual controller during the reporting period [4].